Molecular Partners AG - Special Call Transcript
(technical difficulty)
perhaps in Europe listening on the webcast. My name is Seth Lewis. I recently joined Molecular Partners as Senior Vice President, Investor Relations Communications, based here in the U.S. Very excited to welcome you all here today to share with you the Molecular Partners update. This program themed Novel Therapeutic Designs Applied. Very exciting panel of speakers, both internally and externally, quite a packed presentation set up this morning.
As you'll be aware, we are a public company, and we will be making various forward-looking statements. I'll refer you to our disclosures. Just want to turn to the agenda and kick things off. As you'll see, as I mentioned, both combination of folks from our internal team, both from the CEO and from our Chief Medical Officer and our Discovery team, but then also from our external experts who have been kind enough to join us, who will speak across our portfolio.
One of the things that I hope you'll get today is some of the excitement that I
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |